» Authors » Hanna K Gaggin

Hanna K Gaggin

Explore the profile of Hanna K Gaggin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 2393
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gaggin H, Greene S, Zhou M, Lautsch D, Bash L, Djatche L, et al.
Int J Cardiol Cardiovasc Risk Prev . 2024 May; 21:200278. PMID: 38766664
Background: Based on available data from randomized clinical trials, patients with heart failure with reduced ejection fraction (HFrEF) and worsening HF events (WHFE) have substantial disease burden and poor outcomes....
2.
Greene S, Gaggin H, Zhou M, Bash L, Lautsch D, Djatche L, et al.
ESC Heart Fail . 2024 Apr; 11(4):1932-1946. PMID: 38639469
Aims: Patients with HFrEF and worsening HF events (WHFE) are at particularly high risk and urgently need disease-modifying therapy. CHART-HF assessed treatment patterns and reasons for medication decisions among HFrEF...
3.
Hoteit A, Casimero F, Stone J, Cameron D, Isselbacher E, Seyedsadjadi R, et al.
JACC Case Rep . 2024 Apr; 29(9):102311. PMID: 38576771
Amyloid deposition in aortic tissue is associated with increased stiffness. We report a patient with ascending aortic aneurysm and chronic abdominal aortic dissection who had significant wild-type transthyretin amyloid deposition ...
4.
Gandhi P, Herman P, Gaggin H
JACC Heart Fail . 2024 Jan; 12(3):475-478. PMID: 38206237
No abstract available.
5.
Liu X, Xing F, Gaggin H, Kuo C, El Fakhri G, Woo J
Proc IEEE Int Symp Biomed Imaging . 2023 Nov; 2023. PMID: 38031559
Cardiac cine magnetic resonance imaging (MRI) has been used to characterize cardiovascular diseases (CVD), often providing a noninvasive phenotyping tool. While recently flourished deep learning based approaches using cine MRI...
6.
Kennedy S, Gaggin H
J Card Fail . 2023 Mar; 29(4):459-462. PMID: 36907236
No abstract available.
7.
Mohebi R, Liu Y, Murphy S, Gaggin H, Januzzi Jr J
Int J Cardiol . 2023 Mar; 378:71-76. PMID: 36870449
Background: End-stage (Stage D) heart failure with preserved ejection fraction (HFpEF) is a poorly characterized syndrome that has heterogeneous underlying pathophysiology. A better characterization of the various clinical profiles of...
8.
Alzate J, Rajendran P, Gaggin H
Circ Heart Fail . 2022 Nov; 16(1):e010156. PMID: 36408700
No abstract available.
9.
Mohebi R, Liu Y, van Kimmenade R, Gaggin H, Murphy S, Januzzi Jr J
Eur J Heart Fail . 2022 Nov; 25(2):152-160. PMID: 36394549
Aim: We sought to investigate the association of inflammatory biomarkers with incident heart failure (HF) events in patients at different stages of HF. Methods And Results: Overall, 1231 study participants...
10.
Taylor C, Gaggin H
JACC Asia . 2022 Nov; 1(3):314-316. PMID: 36341213
No abstract available.